Bookmark

Add to MyYahoo RSS

Merck News

News on Merck (Ticker: MRK) continually updated from thousands of sources around the net.

12 hrs ago | Seeking Alpha

Bad Times Continue To Hit Merck's Animal Health Segment

Withdrawal of Zilmax plopped down the animal health segment's contribution by almost 5% on a year over year basis.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Eli Lilly, Product Recalls

Mon Jul 21, 2014

Bloomberg

AIDS Cure Quest Advances as Cancer Drug Rouses Hidden HIV

AIDS researchers seeking to cure HIV with a one-two punch got an early hint the approach may work by successfully using an old cancer drug to kick the virus out of hiding in a pilot study in Denmark .

Comment?

Related Topix: HIV/AIDS, Health, Infectious Diseases, Medicine, Biotech, Healthcare Industry, Summit, NJ

Forbes.com

Interesting August Stock Options for Merck

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Merck & Co ., Inc .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets

Barron's

Gilead Sciences: Sovaldi's a Blockbuster, the Question is How Big

We all know Gilead Sciences' hepatitis C treatment, Sovalidi, has been a blockbuster.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Johnson and Johnson

Sun Jul 20, 2014

Free Republic

Do Massive Layoffs Really Benefit Companies?

Microsoft's recent announcement that it will cut 18,000 jobs was much higher than anyone expected.

Comment?

Related Topix: Microsoft, Tellme, Startups, Groove Commerce, Sentillion, Biotech, Medicine, Healthcare Industry

Thu Jul 17, 2014

Value Line

Drug Roundup - July 17, 2014

There have been several noteworthy developments in the drug space recently, which will likely have a material impact on the companies in this sector and the markets they serve.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Eli Lilly, Bloomsbury Publishing, Bristol Myers Squibb, Publishing, Media, Pharmaceuticals

Wed Jul 16, 2014

Customer Interaction Solutions

Alexion Announces the Appointments of David R. Brennan, M. Michele...

Alexion Pharmaceuticals, Inc. today announced the appointments of David R. Brennan, M. Michele Burns and Christopher J. Coughlin to the Company's Board of Directors, effective immediately.

Comment?

Related Topix: Alexion Pharmaceuticals, Biotech, Medicine, Healthcare Industry, AstraZeneca, AstraZeneca Group, Insurance, Marsh and Mclennan Companies

Seeking Alpha

Cramer's Lightning Round - General Electric Needs To Bring Good Things To Life

Merck , Bristol Myers , Johnson & Johnson : "I would rather see you in Merck or Bristol Myers .

Comment?

Related Topix: Biotech, General Electric, Medicine, Financial Services, Aerospace-Defense, Healthcare Industry, Johnson and Johnson, Bristol Myers Squibb, Johnson Controls, Startups, VIVUS

Mon Jul 14, 2014

SchaeffersResearch.com

Record-Setting Day Leaves Dow Jones Industrial Average Back Above 17K

Stocks started the week on a positive note, with the Dow Jones Industrial Average rallying to a new record high by midday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets, Opinion, Day Trading, Personal Finance

Forbes.com

Interesting August Stock Options for Merck

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Merck & Co ., Inc .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets

PE Hub

Flagship Ventures expands team with new addition

Flagship Ventures, a leading venture capital and venture creation firm focused on healthcare and sustainability, today announced the appointment of Roger J. Pomerantz, M.D., F.A.C.P., as a Senior Partner.

Comment?

Related Topix: Venture Capital, Emerging Technology, Biotech, Medicine, Healthcare Industry, Infectious Diseases, Johns Hopkins University

Sat Jul 12, 2014

Reuters

Merck KGaA pharma chief says looking at mid-size deals - paper

German chemicals and drugs company Merck KGaA is in the market for mid-size acquisitions to bolster its pharmaceuticals division, the head of that unit told Swiss business paper Finanz und Wirtschaft.

Comment?

Related Topix: Biotech, Merck KGaA, Medicine, Healthcare Industry

Fri Jul 11, 2014

Reuters

DEALTALK-Private equity takes on Big Pharma's carve-out challenge

Big Pharma companies are trying to offload low-growth, mature drug portfolios to firms such as Blackstone Group LP and TPG Capital LP which need to figure out how to carve them out, in one of private equity's greatest dealmaking challenges.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

InvestorIdeas.com

Turnaround Stories Lead Reni Benjamin's Biotech Front-Runners

July 11, 2014 The biotech bull market is not over. That's the judgment of Reni Benjamin of H.C. Wainwright & Co., who predicts high quality data from a broad range of small- and mid-cap biotechs will move shares higher during the summer and especially in the fall.

Comment?

Related Topix: Biotech, Science / Technology, Gilead Sciences, Healthcare Industry, Startups, CGI Pharmaceuticals

Thu Jul 10, 2014

Freshnews

Medivation Announces Change in Executive Management Team

Ms. Svoronos currently is a member of Medivation's Board of Directors and is a former president of Europe and Canada for Merck & Co.

Comment?

Related Topix: Startups, Medivation, Biotech, Medicine, Healthcare Industry, Prostate Cancer, Health

BioSpace

Jounce Therapeutics Snags Ex-Merck & Co., Inc. Exec For CEO Post

Jounce Therapeutics Appoints Richard Murray, Ph.D., to Chief Executive Officer Strong Leadership Team in Place to Advance Novel Immunotherapy Programs Cambridge, Mass.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Cambridge, MA, Cancer, Health, Science / Technology

Wed Jul 09, 2014

Reuters

Credit Suisse names vice chairman of healthcare group -memo

Credit Suisse AG has named senior banker Tom Davidson vice chairman of its global healthcare group, according to a memo released to employees on Wednesday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Genzyme General, Acambis

Tue Jul 08, 2014

AmericanBankingNews.com

Merck & Co. PT Raised to $60.00

Leerink Swann's target price suggests a potential upside of 3.15% from the company's current price.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Merck & Co.

Mon Jul 07, 2014

Bloomberg

Belgium's Omega Pharma Said to Explore Sale After Merck OTC Deal

Omega Pharma NV, the Belgian over-the-counter health-care company, is exploring a sale of the business almost three years after it was taken private by its founder, people familiar with the matter said.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Stanley, Whitehouse Station, NJ

BioSpace

Merck & Co., Inc. Uses Legal Threats To Silence Negative Advice About Zetia And Vytorin In Italy

In response to repeated legal threats, a public health doctor in Italy has withdrawn advice to curtail use of a controversial drug.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Zetia, Ezetimibe (generic)

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••